Phillip Faithfull, now 66, contracted HIV in the mid-1980s but did not begin treatment until 2007, when he became ill with ...

The President’s Emergency Plan for AIDS Relief, or PEPFAR, is credited with saving 25 million lives worldwide and has long ...

A unique reaction in which antibodies bind to other antibodies may help scientists at Scripps Research better understand how ...

But just seven years ago, and despite living with HIV for nearly half his life, Duffy was remarkably healthy, working in ...

Zimbabwe's finance minister expressed concern on Wednesday that a U.S. withdrawal from the World Health Organization will ...

A meta-analysis found a low risk of HIV transmission in people taking antiretroviral therapy (ART) in high-income countries.

This new generic medicine is designed to be a simple, once-daily treatment for children as young as three months old who ...

Scientists discovered that repetitive HIV vaccinations can lead the body to produce antibodies targeting the immune complexes ...

So far, the FDA has approved the drug only for people who already have HIV that’s resistant to other treatments. But its ...

Real-world analyses have confirmed the efficacy of the 2-drug regimen of dolutegravir and lamivudine in treating HIV, ...

Many vaccines work by introducing a protein to the body that resembles part of a virus. Ideally, the immune system will produce long-lasting antibodies recognizing that specific virus, thereby ...

"President Trump claims to be a strong proponent of freedom of speech, yet he is clearly committed to censorship." ...